| Pharmacogenetic-Based Efavirenz Dose Modification: Suggestions for an African Population and the Different CYP2B6 Genotypes EA Jackson K. Mukonzo, Joel S. Owen, Jasper Ogwal-Okeng, Ronald B. Kuteesa ... Plos One 9 (1), 2014 | 80 | 2014 |
| A survey of machine learning applications in HIV clinical research and care KR Bisaso, GT Anguzu, SA Karungi, A Kiragga, B Castelnuovo Computers in biology and medicine 91, 366-371, 2017 | 60 | 2017 |
| A comparative study of logistic regression based machine learning techniques for prediction of early virological suppression in antiretroviral initiating HIV patients KR Bisaso, SA Karungi, A Kiragga, JK Mukonzo, B Castelnuovo BMC Medical Informatics and Decision Making 18, 77, 2018 | 42 | 2018 |
| Intermittent use of sulphadoxine-pyrimethamine for malaria prevention: A cross-sectional study of knowledge and practices among Ugandan women attending an urban antenatal clinic CO Odongo, KR Bisaso, J Byamugisha, C Obua Malaria Journal 13, 399, 2014 | 34 | 2014 |
| Characterizing plasma albumin concentration changes in TB/HIV patients on anti retroviral and anti–tuberculosis therapy KR Bisaso, JS Owen, FW Ojara, PM Namuwenge, A Mugisha, ... In Silico Pharmacology 2, 1-8, 2014 | 24 | 2014 |
| CYP2B6 genotype-based efavirenz dose recommendations during rifampicin-based antituberculosis cotreatment for a sub-Saharan Africa population AE Mukonzo J K, Bisaso R K, Ogwal-Okeng J, Gustafsson L L, Owen J S Pharmacogenomics 17 (6), 603-613., 2016 | 19 | 2016 |
| Role of pharmacogenetics in rifampicin pharmacokinetics and the potential effect on TB–rifampicin sensitivity among Ugandan patients JK Mukonzo, A Kengo, B Kutesa, S Nanzigu, A Pohanka, TD McHugh, ... Transactions of The Royal Society of Tropical Medicine and Hygiene 114 (2 …, 2020 | 14 | 2020 |
| Trimester-specific population pharmacokinetics and other correlates of variability in sulphadoxine–pyrimethamine disposition among Ugandan pregnant women CO Odongo, KR Bisaso, M Ntale, G Odia, FW Ojara, J Byamugisha, ... Drugs in R&D 15, 351-362, 2015 | 12 | 2015 |
| Is there a distinction between malaria treatment and intermittent preventive treatment? Insights from a cross-sectional study of anti-malarial drug use among Ugandan pregnant women CO Odongo, KR Bisaso, F Kitutu, C Obua, J Byamugisha Malaria Journal 14, 1-8, 2015 | 12 | 2015 |
| Population pharmacokinetic, pharmacogenetic, and pharmacodynamic analysis of cyclophosphamide in Ethiopian breast cancer patients JH Ahmed, E Makonnen, RK Bisaso, JK Mukonzo, A Fotoohi, A Aseffa, ... Frontiers in pharmacology 11, 406, 2020 | 9 | 2020 |
| Can malaria rapid diagnostic tests by drug sellers under field conditions classify children 5 years old or less with or without Plasmodium falciparum malaria … FE Kitutu, H Wamani, KE Selling, FA Katabazi, RB Kuteesa, S Peterson, ... Malaria journal 17, 1-12, 2018 | 8 | 2018 |
| Markov model for characterizing neuropsychologic impairment and Monte Carlo simulation for optimizing efavirenz therapy KR Bisaso, JK Mukonzo, EI Ette The Journal of Clinical Pharmacology 55 (11), 1229-1235, 2015 | 8 | 2015 |
| Transition modeling of neuropsychiatric impairment in HIV KR Bisaso, JK Mukonzo, EI Ette Computers in biology and medicine 73, 141-146, 2016 | 4 | 2016 |
| Stimulus–Response mechanistic modeling of pharmacodynamic drug-drug interaction: Extension of the operational receptor model of agonism KR Bisaso, JK Mukonzo, EI Ette Informatics in Medicine Unlocked 28, 100813, 2022 | 2 | 2022 |
| HIV, tuberculosis, diabetes mellitus and hypertension admissions and premature mortality among adults in Uganda from 2011 to 2019: is the tide turning? A Kazibwe, KR Bisaso, AP Kyazze, S Ninsiima, P Ssekamatte, ... Tropical medicine and health 50 (1), 54, 2022 | 1 | 2022 |
| Maximizing Knowledge Extraction From Patient‐Reported Outcome Data Using Exposure‐Outcome Item Response Modeling Approach: Understanding Efavirenz‐Induced Central Nervous … KS Bisaso, KR Bisaso, JK Mukonzo, EI Ette The Journal of Clinical Pharmacology 60 (6), 711-721, 2020 | 1 | 2020 |
| A mechanistic assessment of the nature of pharmacodynamic drug-drug interaction in vivo and in vitro KR Bisaso, JK Mukonzo, EI Ette In Silico Pharmacology 11 (1), 31, 2023 | | 2023 |
| Towards Improved Management of Tuberculous Bloodstream Infections: Pharmacokinetic Considerations with Suggestions for Better Treatment Outcomes CO Odongo, L Nakiyingi, CG Nkeramihigo, D Seifu, KR Bisaso Antibiotics 11 (7), 895, 2022 | | 2022 |
| Towards Improved Management of Tuberculous Bloodstream Infections: Pharmacokinetic Considerations with Suggestions for Better Treatment Outcomes. Antibiotics 2022, 11, 895 CO Odongo, L Nakiyingi, CG Nkeramihigo, D Seifu, KR Bisaso s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
| Effect of Efavirenz on Endogenous Progesterone Concentrations and Contraceptive Outcomes among Ugandan HIV Infected Women Coadministering Ethinylestradiol/Levonorgestrel G Munkwase, KR Bisaso, O Kakaire, S Nanzigu AIDS Research and Treatment 2017, 2017 | | 2017 |
